Whether or not they draw upon the power of personalized medicine, biopharmaceuticals are changing the face of drug development today.
Whether or not they draw upon the power of personalized medicine, biopharmaceuticals are changing the face of drug development today. Select Science presents bi-specific antibodies and oligonucleotide therapeutics as just two among significant biopharmaceuticals poised to make headlines in 2024. Bi-specific antibodies have proven effective in cancer treatment, while oligonucleotide therapeutics antibodies have the potential to address a variety of genetic and infectious diseases.